Supplementary Figure 6 from &lt;i&gt;p53-Inducible Ribonucleotide Reductase&lt;/i&gt; (&lt;i&gt;p53R2/RRM2B&lt;/i&gt;) Is a DNA Hypomethylation–Independent Decitabine Gene Target That Correlates with Clinical Response in Myelodysplastic Syndrome/Acute Myelogenous Leukemia